Literature DB >> 29541221

Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines.

Qian Li1, Jiao Chen1, Xiaoying Li1, Bomiao Cui1, Yaping Fan1, Ning Geng1, Qianming Chen1, Ping Zhang1, Yun Feng1.   

Abstract

High mobility group nucleosomal-binding domain 2 (HMGN2) is an abundant non-histone nuclear protein of vertebrates and invertebrates. The aim of the present study was to characterize the endogenous expression of HMGN2 in various types of tumor cell. Western blotting was performed to analyze HMGN2 expression in the following tumor cell lines: H1975, HSC-4, MDA-MB-468, MDA-MB-231, SCC-25 and THP-1. Periodontal ligament cells (PDLCs) were included as a noncancerous control. HMGN2 was detected in human oral squamous cell carcinoma tissues by immunohistochemical analysis. The results demonstrated that the expression of HMGN2 was increased in the majority of tumor cell lines, particularly MDA-MB-468 and THP-1 cells, compared with PDLCs. The expression of HMGN2 in oral squamous cell carcinoma tissue was significantly increased compared with the expression in normal tissue. Furthermore, the expression of HMGN2 in metastatic oral squamous cell carcinoma tissues was increased compared with that in its non-metastatic counterpart. These results indicated that HMGN2 may serve an important function in the growth and metastasis of tumor cells.

Entities:  

Keywords:  high mobility group nucleosomal-binding domain 2; oral squamous cell carcinoma; tumor cells

Year:  2018        PMID: 29541221      PMCID: PMC5835874          DOI: 10.3892/ol.2018.7898

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

1.  Revised nomenclature for high mobility group (HMG) chromosomal proteins.

Authors:  M Bustin
Journal:  Trends Biochem Sci       Date:  2001-03       Impact factor: 13.807

Review 2.  High mobility group (HMG) proteins: Modulators of chromatin structure and DNA repair in mammalian cells.

Authors:  Raymond Reeves
Journal:  DNA Repair (Amst)       Date:  2015-09-16

3.  In vitro culture of periodontal ligament cells.

Authors:  L F Arnold; P Baram
Journal:  J Dent Res       Date:  1972 Jul-Aug       Impact factor: 6.116

4.  Overexpression and elevated plasma level of tumor-associated antigen 90K/Mac-2 binding protein in colorectal carcinoma.

Authors:  Chih-Ching Wu; Yu-Shan Huang; Li-Yu Lee; Ying Liang; Rei-Ping Tang; Yu-Sun Chang; Ling-Ling Hsieh; Jau-Song Yu
Journal:  Proteomics Clin Appl       Date:  2008-10-07       Impact factor: 3.494

Review 5.  The HMGN family of chromatin-binding proteins: dynamic modulators of epigenetic processes.

Authors:  Jamie E Kugler; Tao Deng; Michael Bustin
Journal:  Biochim Biophys Acta       Date:  2012-02-02

Review 6.  HMGNs, DNA repair and cancer.

Authors:  Gabi Gerlitz
Journal:  Biochim Biophys Acta       Date:  2009-12-08

Review 7.  Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy.

Authors:  S Choi; J N Myers
Journal:  J Dent Res       Date:  2008-01       Impact factor: 6.116

8.  Effects of HMGN variants on the cellular transcription profile.

Authors:  Mark Rochman; Leila Taher; Toshihiro Kurahashi; Srujana Cherukuri; Vladimir N Uversky; David Landsman; Ivan Ovcharenko; Michael Bustin
Journal:  Nucleic Acids Res       Date:  2011-01-28       Impact factor: 16.971

9.  Nucleosome structural changes induced by binding of non-histone chromosomal proteins HMGN1 and HMGN2.

Authors:  Hideto Shimahara; Takaaki Hirano; Kouichi Ohya; Shun Matsuta; Sailaja S Seeram; Shin-Ichi Tate
Journal:  FEBS Open Bio       Date:  2013-03-28       Impact factor: 2.693

10.  Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis.

Authors:  Ping Xie; Lu-Xia Deng; Ping Gong; Yi Ding; Xiao-Hai Tang
Journal:  Braz J Microbiol       Date:  2011-09-01       Impact factor: 2.476

View more
  4 in total

1.  HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort.

Authors:  Elyse C Page; Susan L Heatley; Laura N Eadie; Barbara J McClure; Charles E de Bock; Sofia Omari; David T Yeung; Timothy P Hughes; Paul Q Thomas; Deborah L White
Journal:  Oncogene       Date:  2021-12-02       Impact factor: 9.867

2.  Recombinant jurkat cells (HMGN2-T cells) secrete cytokines and inhibit the growth of tumor cells.

Authors:  Huanhuan Li; Xueqiang Wu; Dingfang Bu; Lihua Wang; Xueju Xu; Yingchao Wang; Yufeng Liu; Ping Zhu
Journal:  J Mol Histol       Date:  2022-07-21       Impact factor: 3.156

3.  FGF8 induces epithelial-mesenchymal transition and promotes metastasis in oral squamous cell carcinoma.

Authors:  Yilong Hao; Yanxuan Xiao; Xiaoyu Liao; Shuya Tang; Xiaoyan Xie; Rui Liu; Qianming Chen
Journal:  Int J Oral Sci       Date:  2021-03-01       Impact factor: 6.344

4.  Exogenous HMGN2 inhibits the migration and invasion of osteosarcoma cell lines.

Authors:  Enjie Xu; Heng Jiang; Tao Lin; Yichen Meng; Xiao Ma; Jia Yin; Jun Ma; Xuhui Zhou
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.